These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tissue factor and its inhibition at the human microvascular anastomosis. Dumanian GA; Heil BV; Khouri RK; Hong C; Labadie K; Wun TC; Johnson PC J Surg Res; 1996 Jan; 60(1):263-9. PubMed ID: 8592425 [TBL] [Abstract][Full Text] [Related]
5. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma. Khouri RK; Koudsi B; Kaiding F; Ornberg RL; Wun TC Ann Plast Surg; 1993 May; 30(5):398-402; discussion 402-4. PubMed ID: 8342923 [TBL] [Abstract][Full Text] [Related]
12. [Influence of human tissue factor pathway inhibitor gene transfection on neointima formation in vein grafts]. Li Q; Zhang K; Jiang X; Sun T; Wu L; Zhou C; Chen S Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):354-8. PubMed ID: 18396721 [TBL] [Abstract][Full Text] [Related]
13. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis]. Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470 [TBL] [Abstract][Full Text] [Related]
16. Electromicroscopic observations on small vessels in animals treated with sulfinpyrazone and placebo following vascular microsurgery. Brunelli G; Vigasio A; Mukenge S; Verdecchia P Int Surg; 1982; 67(2):163-8. PubMed ID: 7118474 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Caplice NM; Panetta C; Peterson TE; Kleppe LS; Mueske CS; Kostner GM; Broze GJ; Simari RD Blood; 2001 Nov; 98(10):2980-7. PubMed ID: 11698280 [TBL] [Abstract][Full Text] [Related]
18. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145 [TBL] [Abstract][Full Text] [Related]
19. Tissue factor pathway inhibitor; its structure, function and clinical significance. Kato H Pol J Pharmacol; 1996; 48(1):67-72. PubMed ID: 9112630 [TBL] [Abstract][Full Text] [Related]
20. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis. Pan S; Kleppe LS; Witt TA; Mueske CS; Simari RD Thromb Haemost; 2004 Sep; 92(3):495-502. PubMed ID: 15351845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]